165 related articles for article (PubMed ID: 25857773)
21. Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Galmarini CM; Mackey JR; Dumontet C
Leukemia; 2001 Jun; 15(6):875-90. PubMed ID: 11417472
[TBL] [Abstract][Full Text] [Related]
22. Allosteric regulation and substrate activation in cytosolic nucleotidase II from Legionella pneumophila.
Srinivasan B; Forouhar F; Shukla A; Sampangi C; Kulkarni S; Abashidze M; Seetharaman J; Lew S; Mao L; Acton TB; Xiao R; Everett JK; Montelione GT; Tong L; Balaram H
FEBS J; 2014 Mar; 281(6):1613-1628. PubMed ID: 24456211
[TBL] [Abstract][Full Text] [Related]
23. Cytosolic 5'-Nucleotidase III and Nucleoside Triphosphate Diphosphohydrolase 1 Dephosphorylate the Pharmacologically Active Metabolites of Gemcitabine and Emtricitabine.
Phulara NR; Ishida CT; Espenshade PJ; Seneviratne HK
Drug Metab Dispos; 2024 Mar; 52(4):288-295. PubMed ID: 38331874
[TBL] [Abstract][Full Text] [Related]
24. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
[TBL] [Abstract][Full Text] [Related]
25. IMP-GMP 5'-nucleotidase.
Itoh R
Comp Biochem Physiol B; 1993 May; 105(1):13-9. PubMed ID: 8389266
[No Abstract] [Full Text] [Related]
26. On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications.
Tozzi MG; Pesi R; Allegrini S
Curr Med Chem; 2013; 20(34):4285-91. PubMed ID: 23992310
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
Itoh R
Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
[TBL] [Abstract][Full Text] [Related]
28. Bovine cytosolic IMP/GMP-specific 5'-nucleotidase: cloning and expression of active enzyme in Escherichia coli.
Allegrini S; Pesi R; Tozzi MG; Fiol CJ; Johnson RB; Eriksson S
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):483-7. PubMed ID: 9371705
[TBL] [Abstract][Full Text] [Related]
29. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
30. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.
Aksoy P; Zhu MJ; Kalari KR; Moon I; Pelleymounter LL; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2009 Aug; 19(8):567-76. PubMed ID: 19623099
[TBL] [Abstract][Full Text] [Related]
31. Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
Yamamoto S; Yamauchi T; Kawai Y; Takemura H; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Int J Hematol; 2007 Feb; 85(2):108-15. PubMed ID: 17321987
[TBL] [Abstract][Full Text] [Related]
32. Cytosolic 5'-nucleotidase/nucleoside phosphotransferase: a single assay for a bifunctional enzyme.
Allegrini S; Pesi R; Tozzi MG; Ipata PL; Camici M
J Biochem Biophys Methods; 1993 Dec; 27(4):293-9. PubMed ID: 8308194
[TBL] [Abstract][Full Text] [Related]
33. Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.
Hubeek I; Peters GJ; Broekhuizen AJ; Kaspers GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1513-6. PubMed ID: 15571288
[TBL] [Abstract][Full Text] [Related]
34. Expression of bovine cytosolic 5'-nucleotidase (cN-II) in yeast: nucleotide pools disturbance and its consequences on growth and homologous recombination.
Allegrini S; Filoni DN; Galli A; Collavoli A; Pesi R; Camici M; Tozzi MG
PLoS One; 2013; 8(5):e63914. PubMed ID: 23691116
[TBL] [Abstract][Full Text] [Related]
35. Cytosolic 5'-nucleotidase/nucleoside phosphotransferase: a nucleoside analog activating enzyme?
Turriani M; Pesi R; Nardone A; Turchi G; Sgarrella F; Ipata PL; Tozzi MG
J Biochem Toxicol; 1994 Feb; 9(1):51-7. PubMed ID: 8151632
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.
Walldén K; Stenmark P; Nyman T; Flodin S; Gräslund S; Loppnau P; Bianchi V; Nordlund P
J Biol Chem; 2007 Jun; 282(24):17828-36. PubMed ID: 17405878
[TBL] [Abstract][Full Text] [Related]
37. Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.
Ferrandina G; Mey V; Nannizzi S; Ricciardi S; Petrillo M; Ferlini C; Danesi R; Scambia G; Del Tacca M
Cancer Chemother Pharmacol; 2010 Mar; 65(4):679-86. PubMed ID: 19639316
[TBL] [Abstract][Full Text] [Related]
38. Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells.
Iwasaki H; Huang P; Keating MJ; Plunkett W
Blood; 1997 Jul; 90(1):270-8. PubMed ID: 9207462
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.
Serova M; Galmarini CM; Ghoul A; Benhadji K; Green SR; Chiao J; Faivre S; Cvitkovic E; Le Tourneau C; Calvo F; Raymond E
Br J Cancer; 2007 Sep; 97(5):628-36. PubMed ID: 17637678
[TBL] [Abstract][Full Text] [Related]
40. Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.
Galmarini CM; Warren G; Senanayake MT; Vinogradov SV
Int J Pharm; 2010 Aug; 395(1-2):281-9. PubMed ID: 20580798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
